Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-Guided HA vs Corticosteroid for Trigger Finger
NCT04645303Phase 1Unknown
- Sponsor
- Dubai Health Authority
- Start
- Nov 2020
- Primary completion
- Apr 2021
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of hyaluronic acid in trigger finger (2 arms), sponsored by Dubai Health Authority. Primary endpoint: Change in Quinnell trigger finger grading system at 3 months. Status: unknown.
02
Drugs
hyaluronic acid
03
Conditions
trigger finger
Beyond the preview
Go deeper on NCT04645303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04645303.